COX-2 Expressionin Non-Small Cell Lung Cancer and Its Relationship with Clinical Pathology
Hua Zhang
Abstract
Hua Zhang
Abstract
Objective: To study the expression of cyclooxygenase-2(COX-2) in non-small cell lung cancer and para carcinoma tissues and its clinicopathological significance.Methods The expression of COX-2, by PV-9000immunohistochemistrical method in 80 cases of non-small cell lung cancer and 40 cases para carcinoma tissues.Results(1) COX-2 was expressed in tumor tissues and cancer side organizations, but positive expression of COX-2was significantly higher organized in the tissues of non-small cell lung cancer than in the cancer side organizations.Among them, COX-2's positive expression rate in non-small cell lung cancer was 88.75 %, while was 13.33% in the lung cancer side organizations.(2) The expression of COX-2 in non-small cell lung cancer had no significant difference between gender, local and histologic type(P0.05).The over expression of COX-2 was related with clinical pathologic parameters, such as tumor size, histologic grade, lymphatic metastasis and clinical staging(P0.05).Conclusions COX-2 express high existence in the tissues of non-small cell lung cancer, which show they were highly associated with theoccurrenceand developmentofthenon-smallcelllungcancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the expression of cyclooxygenase-2(COX-2) in non-small cell lung cancer and para carcinoma tissues and its clinicopathological significance.Methods The expression of COX-2, by PV-9000immunohistochemistrical method in 80 cases of non-small cell lung cancer and 40 cases para carcinoma tissues.Results(1) COX-2 was expressed in tumor tissues and cancer side organizations, but positive expression of COX-2was significantly higher organized in the tissues of non-small cell lung cancer than in the cancer side organizations.Among them, COX-2's positive expression rate in non-small cell lung cancer was 88.75 %, while was 13.33% in the lung cancer side organizations.(2) The expression of COX-2 in non-small cell lung cancer had no significant difference between gender, local and histologic type(P0.05).The over expression of COX-2 was related with clinical pathologic parameters, such as tumor size, histologic grade, lymphatic metastasis and clinical staging(P0.05).Conclusions COX-2 express high existence in the tissues of non-small cell lung cancer, which show they were highly associated with theoccurrenceand developmentofthenon-smallcelllungcancer.
Key concepts: Lung cancer, Medicine, Pathology, Cancer, Proportional hazards model, Metastasis, Carcinoma, Lung